THYMOMA TYPE B3

Clinical trials for THYMOMA TYPE B3 explained in plain language.

Never miss a new study

Get alerted when new THYMOMA TYPE B3 trials appear

Sign up with your email to follow new studies for THYMOMA TYPE B3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Immunotherapy drug nivolumab tested for rare thymus cancers

Disease control Ongoing

This phase 2 trial is testing the immunotherapy drug nivolumab in 55 patients with type B3 thymoma or thymic carcinoma that has worsened after platinum-based chemotherapy. The main goal is to see if nivolumab can stop the cancer from growing for at least 6 months. Researchers wil…

Matched conditions: THYMOMA TYPE B3

Phase: PHASE2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control

Last updated Jun 27, 2026 12:34 UTC

THYMOMA TYPE B3

Get alerted when new THYMOMA TYPE B3 trials appear

Immunotherapy drug nivolumab tested for rare thymus cancers